Health Canada
www.hc-sc.gc.ca
Common menu bar links
Consultation - Maximum residue limit (MRL) proposal for Amoxicillin, Neomycin, Ormetoprim, Tetracycline, Chlortetracycline, Oxytetracycline, Tilmicosin, Tricaine Methanesulfonate, Tulathromycin and Zoalene
The online consultation is now closed. The content found on this page is a snapshot of the live consultation as it was presented to the public and contains the content that was open for submissions during the consultation period.
The Veterinary Drugs Directorate (VDD) of Health Products and Food Branch, Health Canada, is considering regulatory amendment which may be of interest to you. More specifically, the VDD is proposing to establish Maximum Residue Limits (MRLs) in Table III Division 15, Part B of the Food and Drug Regulations for amoxicillin, neomycin, ormetoprim, tetracycline, chlortetracycline, oxytetracycline, tilmicosin, tricaine methanesulfonate, tulathromycin and zoalene in edible tissues of food-producing animals as indicated in the following table
How to Get Involved
This consultation is open for comment starting March 12 until May 12, 2010. Please select and read through the link below titled "Letter to Stakeholders". Once read please submit your comments via e-mail or by mail to:
consultationVDD-DMV@hc-sc.gc.ca
Consultations - Veterinary Drugs Directorate
Policy, Regulatory and International Affairs Division
Veterinary Drugs Directorate,
Health Products and Food Branch, Health Canada
Holland Cross Complex
11 Holland Ave.
Ground Floor, Suite 14
Ottawa, Ontario
K1A 0K9
Interested parties are encouraged to provide comments and suggestions by May 12, 2010.
Reporting to Canadians
Health Canada will make the results of this consultation available on this Web site.
If you have any questions, contact us at: consultationVDD-DMV@hc-sc.gc.ca.
